10/08/22 -"The from 4Q22 into 1H23 delayed MBCC closing is annoying but neither changing the significant deal value generation nor our positive view on Sika"
10/08/22 -"The from 4Q22 into 1H23 delayed MBCC closing is annoying but neither changing the significant deal value generation nor our positive view on Sika"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
Corporate broking | NO |
Trading in corporate shares | NO |
Analyst ownership | NO |
Advising of corporate (strategy, marketing, debt, etc) | NO |
Research paid for by corporate | NO |
Provision of corporate access paid for by corporate | NO |
Link between and a banking entity | NO |
Brokerage activity at AlphaValue | NO |